5paisa Capital to acquire Giskard Datatech in ₹121.57 crore AI research deal
What's the deal? 5paisa CapitalDealroom has a profile for this one. Try Dealroom → has approved the acquisition of Giskard DatatechDealroom has a profile for this one. Try Dealroom → for up to ₹1,21,57,49,108, buying 100% of the AI research firm through a mix of cash and shares. The board signed off on July 28, 2026, and shareholders will now vote by postal ballot.
What's the endgame? 5paisa wants to fold Giskard's proprietary algorithms, stock screening tools, and portfolio analytics into its platform. The aim is to boost customer engagement across broking, mutual funds, and wealth management.
How is it structured? Cash will cover up to 1,03,082 Giskard shares, or 58.68% of diluted capital. The remaining 37.65% comes through a preferential issue of 20,50,588 5paisa shares at a 1:31 swap ratio — 31 5paisa shares for each Giskard share.
Giskard equity was valued at ₹11,794 per share by independent valuer Raghav Mandhana, using the discounted cash flow method in a report dated June 18, 2026.
Who benefits? The share swap goes to two Giskard shareholders. Amber Pabreja receives 11,82,588 5paisa shares for a 2.42% stake; Devi Yeshodharan gets 8,68,000 shares for 1.77%. Together they will hold 4.19% of 5paisa.
What could go wrong? The deal needs corporate, statutory, and regulatory sign-offs. Because Giskard holds a Research Analyst registration under the SEBI (Research Analysts) Regulations, 2014, prior approval from the Securities and Exchange Board of IndiaDealroom has a profile for this one. Try Dealroom → (SEBI) is required for the change in control. Completion could take up to six months.
The signal: The acquisition shows brokerages buying AI capability outright rather than building it, betting that data-driven research tools will decide where retail investors trade next.
Read more: ScanX
